The increase in ABCB1 expression in glioblastoma patient samples may be mainly due to increased expression at the blood-tumor barrier, and transporter expression levels in tumor cells seem to play a minor role in drug resistance (Tanaka et al., 1994; Tews et al., 2000; Veringa et al., 2013). Here, ABCB1 is linked to glioblastoma.